White paper
The Project Management Office – Accelerating Project Management Maturity
February 3, 2011Sales and Marketing Kinapse, White paper
Success in the life sciences industry depends on allocation of scarce resource to the right projects at different stages of …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
November 22, 2010Sales and Marketing Kinapse, White paper
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …
Government drops Dr Foster Intelligence
November 17, 2010Sales and Marketing Dr Foster Intelligence, White paper, government, reforms
The government is set to drop the public-private partnership it currently has with Dr Foster Intelligence, its key provider information …
Improving Clinical Site Productivity
November 9, 2010Sales and Marketing Kinapse, White paper
There are a number of factors in the industry that make clinical trials more costly, more time-consuming and requiring more …
New Commercial Realities
November 4, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, pharmaceutical companies must undertake a fundamental and …
Sowing into Good Ground: Using “personalized medicine” for optimal treatment value
October 26, 2010Sales and Marketing Kinapse, White paper
As demonstrating value for the “average patient” becomes ever more difficult, Health Economics and Outcomes Research leaders can use “personalised …
In with the ‘new’: A leaner, fitter biosciences sector – 2010
October 18, 2010Sales and Marketing Kinapse, White paper
The biosciences sector has witnessed numerous challenges during recent years, as the global economic downturn has adversely impacted sector liquidity …
Discovery Innovation – Productive Partnering For Shared Success
October 15, 2010Sales and Marketing Kinapse, White paper
Partnering is an integral feature within today’s pharmaceutical industry. While the conventional wisdom suggests that Phase II represents the optimum …
New Commercial Realities – Part 4 Key implications of this changing industry landscape for pharmaceutical commercial operations – governance
October 5, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the pharmaceutical industry has recognised that traditional …
Outcomes based measures for Pharma new commercial models
September 29, 2010Sales and Marketing Kinapse, White paper
It is now widely recognised that Pharma new commercial models will rely on the principles of account management, working collaboratively …
New Commercial Realities Paper Pt 3 – The changing landscape for pharmaceutical commercial operations – roles and organisational scale
September 29, 2010Sales and Marketing Kinapse, White paper
Faced with a changing healthcare environment and the prospect of diminishing commercial returns, the industry’s traditional commercial models based on …
Realising outsourcing’s potential
September 20, 2010Sales and Marketing Kinapse, White paper
IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2
August 26, 2010Research and Development Kinapse, White paper, life sciences, pharma
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
